Losartan potassium and Ear disorder - a phase IV clinical study of FDA data

Summary:

Ear disorder is reported as a side effect among people who take Losartan potassium (losartan potassium), especially for people who are female, 60+ old, also take Vitamin D3, and have Metastases to bone.

The phase IV clinical study analyzes which people have Ear disorder when taking Losartan potassium. It is created by eHealthMe based on reports of 50,026 people who have side effects when taking Losartan potassium from the FDA, and is updated regularly.

What is Losartan potassium?

Losartan potassium has active ingredients of losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 51,511 Losartan potassium users. Check the latest studies of Losartan potassium.

What is Ear disorder?

Ear disorder is found to be associated with 597 drugs and 1,105 conditions by eHealthMe. Check the latest studies of Ear disorder.

On Jul, 20, 2026

50,026 people reported to have side effects when taking Losartan potassium.
Among them, 24 people (0.05%) have Ear disorder.

Could Losartan potassium cause Ear disorder?

Among these 24 people:

What is the gender of people who have Ear disorder when taking Losartan potassium? *

female: 85.71 %
male: 14.29 %

What is the age of people who have Ear disorder when taking Losartan potassium? *

What are other drugs people take besides Losartan potassium? *

What are other side effects people have besides Ear disorder? *

Feeling Abnormal: 11 people, 45.83%
Hypoacusis (loss of hearing): 10 people, 41.67%
Visual Impairment: 10 people, 41.67%
Ear Pain: 9 people, 37.50%
Fatigue (feeling of tiredness): 9 people, 37.50%
Headache (pain in head): 9 people, 37.50%
Malaise (a feeling of general discomfort or uneasiness): 8 people, 33.33%
Weakness: 8 people, 33.33%
Memory Loss: 8 people, 33.33%
Lymphoedema (localized fluid retention and tissue swelling): 7 people, 29.17%

What are the existing conditions these people have? *

Breast Cancer Female: 7 people, 29.17%
Metastases To Bone (cancer spreads to bone): 7 people, 29.17%
Multiple Myeloma (cancer of the plasma cells): 4 people, 16.67%
High Blood Cholesterol: 2 people, 8.33%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 8.33%
Primary Immunodeficiency Syndrome: 2 people, 8.33%
Immunodeficiency Common Variable: 2 people, 8.33%
Urticaria Chronic (long lasting rash of round, red welts on the skin that itch intensely): 1 person, 4.17%
Glaucoma (increased fluid pressure in the eye with vision loss): 1 person, 4.17%
Macular Oedema (fluid and protein deposits collect on or under the macula of the eye (a yellow central area of the retina) and causes it to thicken): 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Losartan potassium and have Ear disorder?

- Check whether Ear disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Losartan potassium:

Losartan potassium (51,511 reports)

Ear disorder treatments and more:

Ear disorder (6,288 reports)

Browse all side effects of Losartan potassium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ear disorder:

Ear disorder (597 drugs)

Browse all the conditions that are associated with Ear disorder:

Ear disorder (1,105 conditions)

Related publications that referenced our studies

Lai SW, Lin HF, Lin CL, Liao KF, "No association between losartan use and acute pancreatitis in hypertensive patients", Eur J Hosp Pharm, 2017 Mar .
Lai SW, Lin HF, Lin CL, Liao KF, "No association between losartan use and acute pancreatitis in hypertensive patients", Eur J Hosp Pharm, 2017 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on losartan potassium (the active ingredients of Losartan potassium) and Losartan potassium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.